These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability. Caverly LJ; Lu J; Carmody LA; Kalikin LM; Shedden K; Opron K; Azar M; Cahalan S; Foster B; VanDevanter DR; Simon RH; LiPuma JJ Ann Am Thorac Soc; 2019 Dec; 16(12):1534-1542. PubMed ID: 31415187 [No Abstract] [Full Text] [Related]
9. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections. Heirali A; McKeon S; Purighalla S; Storey DG; Rossi L; Costilhes G; Drews SJ; Rabin HR; Surette MG; Parkins MD PLoS One; 2016; 11(2):e0148534. PubMed ID: 26859493 [TBL] [Abstract][Full Text] [Related]
13. The presence of cystic fibrosis-related diabetes modifies the sputum microbiome in cystic fibrosis disease. Vasiljevs S; Witney AA; Baines DL Am J Physiol Lung Cell Mol Physiol; 2024 Feb; 326(2):L125-L134. PubMed ID: 38084404 [TBL] [Abstract][Full Text] [Related]
14. Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation. Harris JK; Wagner BD; Zemanick ET; Robertson CE; Stevens MJ; Heltshe SL; Rowe SM; Sagel SD Ann Am Thorac Soc; 2020 Feb; 17(2):212-220. PubMed ID: 31604026 [No Abstract] [Full Text] [Related]
15. Low Diversity and Instability of the Sinus Microbiota over Time in Adults with Cystic Fibrosis. Armbruster CR; Li K; Kiedrowski MR; Zemke AC; Melvin JA; Moore J; Atteih S; Fitch AC; DuPont M; Manko CD; Weaver ML; Gaston JR; Alcorn JF; Morris A; Methé BA; Lee SE; Bomberger JM Microbiol Spectr; 2022 Oct; 10(5):e0125122. PubMed ID: 36094193 [TBL] [Abstract][Full Text] [Related]
16. Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Airway Microbiome Diversity and Pulmonary Function. Bozzella MJ; Chaney H; Sami I; Koumbourlis A; Bost JE; Zemanick ET; Freishtat RJ; Crandall KA; Hahn A Pediatr Infect Dis J; 2021 Nov; 40(11):962-968. PubMed ID: 34269323 [TBL] [Abstract][Full Text] [Related]
17. Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease. Hogan DA; Willger SD; Dolben EL; Hampton TH; Stanton BA; Morrison HG; Sogin ML; Czum J; Ashare A PLoS One; 2016; 11(3):e0149998. PubMed ID: 26943329 [TBL] [Abstract][Full Text] [Related]
18. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period. de Dios Caballero J; Vida R; Cobo M; Máiz L; Suárez L; Galeano J; Baquero F; Cantón R; Del Campo R mBio; 2017 Sep; 8(5):. PubMed ID: 28951476 [TBL] [Abstract][Full Text] [Related]
19. Longitudinal Associations of the Cystic Fibrosis Airway Microbiome and Volatile Metabolites: A Case Study. Hahn A; Whiteson K; Davis TJ; Phan J; Sami I; Koumbourlis AC; Freishtat RJ; Crandall KA; Bean HD Front Cell Infect Microbiol; 2020; 10():174. PubMed ID: 32411616 [TBL] [Abstract][Full Text] [Related]